Kala Bio, Inc. (NASDAQ:KALA) IPO
IPO
Went public as Kala Pharmaceuticals, Inc. Priced at US$15.00 a share on Jul 19, 2017.
- Price
- US$15.00 a share
- Shares offered
- 6,000,000 shares of common stock
- Offering size
- US$90 million
- Underwriters' option
- Up to 900,000 more shares
- Listing
- KALA on the Nasdaq Global Select Market
- Underwriters
- J.P. Morgan, BofA Merrill Lynch, Wells Fargo Securities, Wedbush PacGrow · In the order on the cover
- Shares delivered
- On or about Jul 25, 2017
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Sep 21, 2015 |
| Filed publicly | Jun 23, 2017 |
| Amended once | Jul 10, 2017 |
| Shares registered with an exchange | Jul 14, 2017 |
| Declared effective by the SEC | Jul 19, 2017 |
| Final prospectus, with the price | Jul 20, 2017 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jul 20, 2017 |
| EFFECT · Notice that a registration is effective | Jul 19, 2017 |
| CORRESP · Letter to the SEC | Jul 17, 2017 |
| CORRESP · Letter to the SEC | Jul 17, 2017 |
| 8-A12B · Registration of shares for listing on an exchange | Jul 14, 2017 |
| S-1/A · Registration statement, amended | Jul 10, 2017 |
| CORRESP · Letter to the SEC | Jun 28, 2017 |
| CORRESP · Letter to the SEC | Jun 23, 2017 |
| S-1 · Registration statement | Jun 23, 2017 |
| UPLOAD · Letter from the SEC | Jun 14, 2017 |
| DRSLTR · Letter to the SEC with a draft | Jun 2, 2017 |
| DRS/A · Draft registration statement, amended | Jun 2, 2017 |
| UPLOAD · Letter from the SEC | Apr 26, 2017 |
| DRS/A · Draft registration statement, amended | Mar 30, 2017 |
| DRS/A · Draft registration statement, amended | Feb 4, 2016 |
| DRSLTR · Letter to the SEC with a draft | Nov 3, 2015 |
| DRS/A · Draft registration statement, amended | Nov 3, 2015 |
| UPLOAD · Letter from the SEC | Oct 20, 2015 |
| DRS · Draft registration statement | Sep 21, 2015 |
From the cover of the final prospectus (424B4) filed Jul 20, 2017